Pharmacokinetics of the new proton pump inhibitor ilaprazole in Chinese healthy subjects in relation to CYP3A5 and CYP2C19 genotypes

There was no demonstrated relationship between ilaprazole metabolism and CYP3A5 polymorphisms.